Abstract
Isolation of Candida sp less susceptible to traditional therapies and recovery of increasingly resistant isolates during antifungal therapy are growing problems. It is important for clinicians to be aware of trends and mechanisms responsible for the expression of resistance.
MeSH terms
-
Antifungal Agents / classification
-
Antifungal Agents / pharmacology*
-
Antifungal Agents / therapeutic use
-
Azoles / pharmacology
-
Azoles / therapeutic use
-
Candida / drug effects*
-
Candida / pathogenicity
-
Drug Resistance, Fungal*
-
Humans
-
Immunocompromised Host
-
Polyenes / pharmacology
-
Polyenes / therapeutic use
Substances
-
Antifungal Agents
-
Azoles
-
Polyenes